CERo Therapeutics (CEROW) Q1 2026 Earnings

Feb 25Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-124.26
-83.09
-41.92
-0.75

Details

Expected EPS
-0.75
Actual EPS
-0.75
Surprise EPS
0
Surprise Percent
+0%

Description

⁨CERo Therapeutics⁩ (⁦CEROW⁩) has reported earnings of ⁦-0.75⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts